Breaking News
0

Knight Therapeutics Inc (GUD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.65 -0.08    -1.03%
15/11 - Closed. Currency in CAD ( Disclaimer )
Type: Equity
Market: Canada
ISIN: CA4990531069 
  • Volume: 261,598
  • Bid/Ask: 7.64 / 7.68
  • Day's Range: 7.63 - 7.82
Knight Therapeutics Inc 7.65 -0.08 -1.03%

GUD Overview

 
This is the main Knight Therapeutics Inc stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close7.73
Day's Range7.63 - 7.82
Revenue14.08M
Open7.75
52 wk Range7.1 - 8.88
EPS0.15
Volume261,598
Market Cap1.04B
Dividend (Yield)N/A (N/A)
Average Vol. (3m)257,356
P/E Ratio51.46
Beta0.76
1-Year Change - 9.25%
Shares Outstanding135,629,136
Next Earnings DateMar 18, 2020
What is your sentiment on Knight Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Knight Therapeutics Inc News


Knight Therapeutics Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Strong Sell Strong Sell Strong Sell Sell
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Belt Hold Bearish 30 Current
Engulfing Bearish 30 Current
Completed Patterns
Bullish Engulfing 1M 1 Oct 19
Three Outside Up 1M 5 Jun 19
Engulfing Bearish 15 5 Nov 15, 2019 02:45PM

Knight Therapeutics Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Toronto 7.65 7.64 7.68 261,598 -1.03% CAD 15/11  
  NEO 7.63 0.00 0.00 2,961 -1.29% CAD 15/11  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 265.76 265.78 263.01 +3.12 +1.19% 25.09M 15/11  
  Facebook 195.10 195.30 193.38 +1.95 +1.01% 11.53M 15/11  
  Alphabet A 1,333.54 1,333.54 1,311.89 +24.39 +1.86% 1.96M 15/11  
  Tesla 352.17 352.80 348.36 +2.82 +0.81% 4.81M 15/11  
  Amazon.com 1,739.49 1,761.68 1,732.86 -15.11 -0.86% 3.93M 15/11  
  Bank of America 32.93 32.96 32.70 +0.23 +0.70% 36.41M 15/11  
  Travelers 133.57 134.69 133.35 -0.38 -0.28% 1.45M 15/11  
  Lululemon Athletica 215.91 216.05 212.26 +2.69 +1.26% 1.49M 15/11  
  Microsoft 149.97 149.99 148.27 +1.91 +1.29% 23.51M 15/11  
  IBM 134.40 135.12 134.03 +0.40 +0.30% 3.26M 15/11  

Knight Therapeutics Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

48

Equity Type

ORD

Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally. Its prescription pharmaceuticals and medical devices in various stages of development include Impavido, AzaSite, ATryn, Photofrin, ILUVIEN, TULSA-PRO, PROBUPHINE, Advaxis Family of Products, Ember Family of Products, NeurAxon Family of Products, Antibe Family of Products, Blood Factor Products and VEWS Vascular Early Warning System. In addition, the Company also has a portfolio of branded consumer health products, including Neuragen, Flat Tummy Tea, FOCUSFactor, FLEXISEQ, SEQuaderma, HandMD, UrgentRx, Laboratoire Dr. Renaud, Premiology and Pro-Derm.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
Securities Investor Protection Corporation (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GUD Comments

Write your thoughts about Knight Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email